GRADE BioMed FIRST - previous events 2021

You will find here an overview of the events of the GRADE Center BioMed FIRST in 2021.


Workshops

Jan 14

 

GxP-Grundlagenkurs
Veranstalter: Pharmaakademie GmbH & Co KG

Feb 3

 

Oncology Perspective Lecture: »mRNA – developing a new pharmaceutical drug class«
with Prof. Ugur Sahin

March 25

 

Basics in drug production and approval
with Dr. Andreas Franken (BAH)

April 15

 

Vortrag:  Impfstoffe gegen SARS-CoV-2  - ein Update
with Dr. Ilse Zündorf

May 4-5

 

Projektmanagement: Projekte erfolgreich umsetzen – klassisch, agil oder was hilft am besten?
mit Petra Becker-Horn

July 19-22

 

Arzneimittelzulassung in Deutschland und Europa
mit Prof. Markus Veit

Aug 3

 

Good Clinical Practice (GCP)
with Dr. Christian Grote-Westrick

Nov 24

 

Laboratory Animal Science for Researchers: Animal models are essential for translation of drug findings from bench to bedside
with Dr. Natasja de Bruine and Dr. Martine Hoffmann

Dec 2-3

 

GLP, GMP, quality control
with Prof. Dr. Mona Tawab, Zentralloratorium Deutscher Apotheker, Eschborn & FB14, GU


*EXTERNAL EVENT* 18th CIMT Annual Meeting

Europe's Cancer Immunotherapy Meeting - online and connected - May 10-12, 2021

Be part of the program by submitting your abstract in the following categories:

  • Therapeutic Vaccination
  • Immunomonitoring
  • Cellular Therapy
  • New Targets & New Leads
  • Tumor Biology and Interaction with the Immune System
  • Improving Immunity


Free conference admission is available for early-career scientists from underrepresented countries. See www.meeting.cimt.eu for more information.

Confirmed Plenary Speakers:
Ugur Sahin (BioNTech), Yvonne Y. Chen (University of California, Los Angeles), Mirjam H.M. Heemskerk (Leiden University Medical Center), Yardena Samuels (Weizmann Institute of Science), Ana Anderson (Harvard Medical School), Sjoerd van der Burg (Leiden University Medical Center), Laurence Zitvogel (Institut Gustave Roussy), Andrea Schietinger (Memorial Sloan Kettering Cancer Center), Robert Seder (NIH-NIAID), Tobias Feuchtinger (Ludwig-Maximilians-Universität), Alexander Rubinsteyn (University of North Carolina), Zlatko Trajanoski (Medical University of Innsbruck), Vincenzo Bronte (University of Verona), Patrick Ott (Dana-Farber Cancer Institute), Hassane M. Zarour (UPMC Hillman Cancer Center), Darrell Irvine (MIT), Ido Amit (Weizmann Institute of Science), Fyza Shaikh (Johns Hopkins School of Medicine)

----------------------------